Skip to main content

Advertisement

SpringerLink
Log in

Preserving Vision in Retinoblastoma Through Early Detection and Intervention

  • Pediatric Oncology (S Epelman, Section Editor)
  • Published:
Current Oncology Reports Aims and scope Submit manuscript

Abstract

The most frequent neoplasm of the eye in children is retinoblastoma. It is a rare disease with an average incidence of 1 in 14,000 to 18,000 live births. The incidence is greater in developing countries. Early detection may allow widespread use of eye-sparing treatments, minimizing the morbidity of this disease. Although leukocoria is usually the first sign that parents notice especially when a flash photograph is taken, the diagnosis is not performed since this presentation is not known by health care providers and the public. Improving public awareness and knowledge of the early signs may lead to early diagnosis, which can save more eyes and lives. Advances in both the basic science and clinical applications of new therapies continue to emerge for this rare cancer. We expect that all conservative treatments will be available worldwide and consequently more children will be cured and maintain the vision.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Stiller CA, Parkin DM. Geographic and ethnic variations in the incidence of childhood cancer. Br Med Bull. 1996;52(4):682–703.

    PubMed  CAS  Google Scholar 

  2. de Camargo B, de Oliveira Santos M, Rebelo MS, et al. Cancer incidence among children and adolescents in Brazil: first report of 14 population-based cancer registries. Int J Cancer. 2011;126(3):715–20.

    Article  Google Scholar 

  3. Fajardo-Gutierrez A, Juarez-Ocana S, Gonzalez-Miranda G, et al. Incidence of cancer in children residing in ten jurisdictions of the Mexican Republic: importance of the cancer registry (a population-based study). BMC Cancer. 2007;7:68.

    Article  PubMed  Google Scholar 

  4. Bekibele CO, Ayede AI, Asaolu OO, et al. Retinoblastoma: the challenges of management in Ibadan, Nigeria. J Pediatr Hematol Oncol. 2009;31(8):552–5.

    Article  PubMed  Google Scholar 

  5. Orjuela M, Castaneda VP, Ridaura C, et al. Presence of human papilloma virus in tumor tissue from children with retinoblastoma: an alternative mechanism for tumor development. Clin Cancer Res. 2000;6(10):4010–6.

    PubMed  CAS  Google Scholar 

  6. Shetty OA, Naresh KN, Banavali SD, et al. Evidence for the presence of high risk human papillomavirus in retinoblastoma tissue from nonfamilial retinoblastoma in developing countries. Pediatr Blood Cancer. 2012;2(58):185–90.

    Article  Google Scholar 

  7. Gillison ML, Chen R, Goshu E, et al. Human retinoblastoma is not caused by known pRb inactivating human DNA tumor viruses. Int J Cancer. 2007;120(7):1482–90.

    Article  PubMed  CAS  Google Scholar 

  8. Mohan A, Venkatesan N, Kandalam M, et al. Detection of human papillomavirus DNA in retinoblastoma samples: a preliminary study. J Pediatr Hematol Oncol. 2009;31(1):8–13.

    Article  PubMed  CAS  Google Scholar 

  9. Lohmann DR, Gallie BL. Retinoblastoma: revisiting the model prototype of inherited cancer. Am J Med Genet. 2004;129C:23–8.

    Article  PubMed  Google Scholar 

  10. Houdayer C, Gauthier-Villars M, Lauge A, et al. Comprehensive screening for constitutional RB1 mutations by DHPLC and QMPSF. Hum Mutat. 2004;23(2):193–202.

    Article  PubMed  CAS  Google Scholar 

  11. Lohmann DR, Brandt B, Hopping W, et al. Distinct RB1 gene mutations with low penetrance in hereditary retinoblastoma. Hum Genet. 1994;94(4):349–54.

    Article  PubMed  CAS  Google Scholar 

  12. Lin P, O’Brien J. Frontiers in the management of retinoblastoma. Am J Ophthalmol. 2009;148:192–8.

    Article  PubMed  CAS  Google Scholar 

  13. Meadows AT, Chintagumpala M, Dunkel IJ, Friedman D, Stoner JA, Villablanca JG. Children’s Oncology Group trials for retinoblastoma. In: Singh A, Damato B, Pe’er J, Murphree AL, Perry JD, editors. Essentials of ophthalmic oncology. Thorofare: SLACK Incorporated; 2009. p. 204–5.

    Google Scholar 

  14. Munier FL, Verwey J, Pica A, et al. New developments in external beam radiotherapy for retinoblastoma: from lens to normal tissue-sparing techniques. Clin Experiment Ophthalmol. 2008;36(1):78–89.

    Article  PubMed  Google Scholar 

  15. Marees T, Moll AC, Imhof SM, et al. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up. J Natl Cancer Inst. 2008;100(24):1771–9.

    Article  PubMed  Google Scholar 

  16. Rodriguez-Galindo C, Wilson MW, Haik BG, et al. Treatment of intraocular retinoblastoma with vincristine and carboplatin. J Clin Oncol. 2003;21(10):2019–25.

    Article  PubMed  CAS  Google Scholar 

  17. Shields CL, Meadows AT, Leahey AM, et al. Continuing challenges in the management of retinoblastoma with chemotherapy. Retina. 2004;24(6):849–62.

    Article  PubMed  Google Scholar 

  18. Chan HS, Gallie BL, Munier FL, et al. Chemotherapy for retinoblastoma. Ophthalmol Clin North Am. 2005;18(1):25–39.

    Article  Google Scholar 

  19. De Potter P. Current treatment of retinoblastoma. Curr Opin Ophthalmol. 2002;13(5):331–6.

    Article  PubMed  Google Scholar 

  20. Rodriguez-Galindo C, Chantada GL, Haik BG, et al. Treatment of retinoblastoma: current status and future perspectives. Curr Treat Options Neurol. 2007;9(4):294–307.

    Article  PubMed  Google Scholar 

  21. Canturk S, Qaddoumi I, Khetan V, et al. Survival of retinoblastoma in less-developed countries. Impact of socioeconomic and health-related indicators. Br J Ophthalmol. 2010;94:1432–36.

    Article  PubMed  CAS  Google Scholar 

  22. Rodriguez-Galindo C, Wilson MW, Chantada G, et al. Retinoblastoma: one world, one vision. Pediatrics. 2008;122(3):e763–770.

    Article  PubMed  Google Scholar 

  23. Erwenne CM, Franco EL. Age and lateness of referral as determinants of extra-ocular retinoblastoma. Ophthalmic Paediatr Genet. 1989;10(3):179–84.

    Article  PubMed  CAS  Google Scholar 

  24. •• Chantada GL, Qaddoumi, Canturk S, et al. Strategies to manage retinoblastoma in developing countries. Pediatr Blood Cancer. 2011;56:341–8. This manuscript shows the importance of early diagnosis and treatment adherence to increase worldwide survival of retinoblastoma.

    Article  PubMed  Google Scholar 

  25. Abramson DH, Frank CM, Susman M, et al. Presenting signs of retinoblastoma. J Pediatr. 1998;132(3 Pt 1):505–8.

    PubMed  CAS  Google Scholar 

  26. Ribeiro K, Antonelli C. Trends in eye cancer mortality among children in Brazil, 1980–2002. Pediatr Blood Cancer. 2007;48:296–305.

    Article  Google Scholar 

  27. Butros LJ, Abramson DH, Dunkel IJ. Delayed Diagnosis of Retinoblastoma: analysis of degree, cause and potential consequences. Pediatrics. 2002;109(3):E45–5.

    Article  PubMed  Google Scholar 

  28. Gallie B, Zhao J, Vandezande K, et al. Global issues and opportunities for optimized Retinoblastoma care. Pediatr Blood Cancer. 2007;49:1083–90.

    Article  PubMed  Google Scholar 

  29. Pakakasama S, Tomlinson. Genetic predisposition and screening in pediatric cancer. Ped Clinics of North America 2002;49.

  30. Donahue SP, Ruben JB, et al. US preventive services task force vision screening recommendations. Pediatrics. 2011;127:569–70.

    Article  PubMed  Google Scholar 

  31. New York State Department of Health. Newborn screening: for your baby’s health. [pamphlet]. Albany: New York State Department; 1996.

    Google Scholar 

  32. Estopinal CB, Donahue SP, Gitschlag GN. Retinoblastoma in a child after normal autorefraction and traditional vision screening. Pediatrics. 2011;128(5):e1285–8.

    Article  PubMed  Google Scholar 

  33. •• Rothschild PR, Lévy D, Savignoni A, et al. Familial retinoblastoma: fundus screening schedule impact and guideline proposal. A retrospective study. Eye (Lond). 2011;25(12):1555–61. This manuscript recommends genetic counseling and an intensive fundus screening for children with a family history of retinoblastoma.

    Article  Google Scholar 

  34. Abramson DH, Beaverson K, Sangani P, et al. Screening for retinoblastoma: presenting signs as prognosticators of patient and ocular survival. Pediatrics. 2003;112:1248–55.

    Article  PubMed  Google Scholar 

  35. Moll AC, Imhof SM, Meeteren AY, et al. At what age could screening for familial retinoblastoma be stopped? A register based study 1945–98. Br J Ophthalmol. 2000;84(10):1170–2.

    Article  PubMed  CAS  Google Scholar 

  36. Drack AV, Labert SR, Stone EM. From the laboratory to the clinic: Molecular genetic testing in pediatric ophthalmology. Am J Ophthalmol. 2010;149:10–7.

    Article  PubMed  Google Scholar 

  37. Chantada GL, Dunkel IJ, Qaddoumi I, et al. Familial retinoblastoma in developing countries. Pediatr Blood Cancer. 2009;53(3):338–42.

    Article  PubMed  Google Scholar 

  38. Leiderman YI, Kiss S, Mukai S. Molecular genetics of RB1—the retinoblastoma gene. Sem Ophthalmol. 2007;22:247–54.

    Article  Google Scholar 

  39. Maat-Kievit JA, Oepkes D, Hartwig NG, et al. A large retinoblastoma detected in a fetus at 21 weeks of gestation. Prenat Diagn. 1993;13(5):377–84.

    Article  PubMed  CAS  Google Scholar 

  40. National Retinoblastoma Strategy Canadian Guidelines for Care. Can J Ophthalmol 2009;44:S10–12.

    Google Scholar 

  41. Wilimas JA, Wilson MW, Haik BG, et al. Development of retinoblastoma programs in Central America. Pediatr Blood Cancer. 2009;53:42–6.

    Article  PubMed  Google Scholar 

  42. Ozdemir H, Tacyildiz N, Unal E. Clinical and epidemiological characteristics of retinoblastoma: correlation with prognosis in a Turkish pediatric oncology center. Pediatr Hematol Oncol. 2007;24(3):221–31.

    Article  PubMed  Google Scholar 

  43. Maki JL. Diagnosis of retinoblastoma: how good are referring physicians? Ophthalmic Genet. 2009;30:199–205.

    Article  PubMed  CAS  Google Scholar 

  44. Navo E, Teplisky D, Albero R, et al. Clinical presentation of retinoblastoma in a middle-income country. J Pediatr Hematol Oncol 2011;24 [Epub ahead of print].

  45. Goddard AG, Kingston JE, Hungerford JL. Delay in diagnosis of retinoblastoma: risk factors and treatment outcome. Br J Ophthalmol. 1999;83:1320–3.

    Article  PubMed  CAS  Google Scholar 

  46. Qaddoumi I, Nawaiseh I, Mehyar M, et al. Team management, twinning, and telemedicine in retinoblastoma: a 3-tier approach implemented in the first eye salvage program in Jordan. Pediatr Blood Cancer. 2008;51(2):241–4.

    Article  PubMed  Google Scholar 

  47. Epelman S, Epelman CL, Erwenne C, et al. National Campaign for early diagnosis of retinoblastoma in Brazil. Procc ASCO. 2005;22:8561.

    Google Scholar 

  48. Leal-Leal C, Dilliz-Nava H, Flores-Rojo M, Robles-Castro J. First contact physicians and retinoblastoma in Mexico. Pediatric Blood Cancer. 2011;57:1109–12.

    Article  PubMed  Google Scholar 

  49. Leander C, Fu LC, Pena A, et al. Impact of an education program on late diagnosis of retinoblastoma in Honduras. Pediatr Blood Cancer. 2007;49(6):817–9.

    Article  PubMed  Google Scholar 

  50. Conway RM, Wheeler SM, Murray TG, et al. Retinoblastoma: animal models. Ophthalmol Clin North Am. 2005;18(1):25–39.

    Article  PubMed  Google Scholar 

  51. • Shields CL, Shields JA. Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy. Curr Opin Ophthalmol. 2010;21(3):203–12. This manuscript describes an update on current management of retinoblastoma with better enucleation implants, chemoreduction, and excellent tumor control, and intra-arterial chemotherapy.

    Article  PubMed  Google Scholar 

  52. Schefler AC, Abramson DH. Retinoblastoma: what is new in 2007–2008. Curr Opin Ophthalmol. 2008;19(6):526–34.

    Article  PubMed  Google Scholar 

  53. Shields JA, Shields CL, De Potter P. Enucleation technique for children with retinoblastoma. J Pediatr Ophthalmol Strabismus. 1992;29(4):213–5.

    PubMed  CAS  Google Scholar 

  54. Abramson DH, Beaverson KL, Chang ST, et al. Outcome following initial external beam radiotherapy in patients with Reese-Ellsworth group Vb retinoblastoma. Arch Ophthalmol. 2004;122(9):1316–23.

    Article  PubMed  Google Scholar 

  55. Shields CL, Mashayekhi A, Sun H, et al. Iodine 125 plaque radiotherapy as salvage treatment for retinoblastoma recurrence after chemoreduction in 84 tumors. Ophthalmology. 2006;113:2087–92.

    Article  PubMed  Google Scholar 

  56. Dunkel IJ, Chan HS, Jubran R, et al. High-dose chemotherapy with autologous hematopoietic stem cell rescue for stage 4B retinoblastoma. Pediatr Blood Cancer. 2010;55(1):149–52.

    PubMed  Google Scholar 

  57. Shields JA, Shields CL, Meadows AT. Chemoreduction in the management of retinoblastoma. Am J Ophthalmol. 2005;140(3):505–6.

    Article  PubMed  Google Scholar 

  58. Lumbroso-Le Rouic L, Aerts I, Levy-Gabriel C, et al. Conservative treatments of intraocular retinoblastoma. Ophthalmology. 2008;115:1405–10.

    Article  PubMed  Google Scholar 

  59. Doz F, Neuenschwander S, Plantaz D, et al. Etoposide and carboplatin in extraocular retinoblastoma: a study by the Societe Francaise d’Oncologie Pediatrique. J Clin Oncol. 1995;13(4):902–9.

    PubMed  CAS  Google Scholar 

  60. Friedman DL, Himelstein B, Shields CL, et al. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol. 2000;18(1):12–7.

    PubMed  CAS  Google Scholar 

  61. Gunduz K, Gunalp I, Yalcindag N, et al. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation. Ophthalmology. 2004;111(10):1917–24.

    Article  PubMed  Google Scholar 

  62. Shields CL, Mashayekhi A, Cater J, et al. Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors. Am J Ophthalmol. 2004;138(3):471–3.

    Article  Google Scholar 

  63. Shields CL, Meadows AT, Shields JA, et al. Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma). Arch Ophthalmol. 2001;119(9):1269–72.

    PubMed  CAS  Google Scholar 

  64. Laurie NA, Gray JK, Zhang J, et al. Topotecan combination chemotherapy in two new rodent models of retinoblastoma. Clin Cancer Res. 2005;11(20):7569–78.

    Article  PubMed  CAS  Google Scholar 

  65. Shields JA, Shields CL, Parsons H, et al. The role of photocoagulation in the management of retinoblastoma. Arch Ophthalmol. 1990;108(2):205–8.

    Article  PubMed  CAS  Google Scholar 

  66. Shields JA, Parsons H, Shields CL, et al. The role of cryotherapy in the management of retinoblastoma. Am J Ophthalmol. 1989;108(3):260–4.

    PubMed  CAS  Google Scholar 

  67. Abramson DH, Schefler AC. Transpupillary thermotherapy as initial treatment for small intraocular retinoblastoma: technique and predictors of success. Ophthalmology. 2004;111(5):984–91.

    Article  PubMed  Google Scholar 

  68. Abramson DH, Marr BP, Dunkel IJ, et al. Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and/or subretinal seeding: 2-year results. Br J Ophthalmol 2011;3 doi:10.1136/bjophthalmol-2011-300498

  69. Abramson DH, Dunkel IJ, Brodie SE, et al. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery). Ophthalmology. 2010;117:1623–9.

    Article  PubMed  Google Scholar 

  70. Shields CL, Kaliki S, Shah SU, Bianciotto CG, Liu D, Jabbour P, et al. Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma. Ophthalmology 2011;Oct 4.

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Pediatric Oncology Department, Santa Marcelina Hospital, São Paulo, Brazil

    Sidnei Epelman

  2. INCTR-Brasil, International Network for Cancer and Treatment Research, São Paulo, Brazil

    Sidnei Epelman

  3. TUCCA, Associação para crianças e adolescentes com cancer, São Paulo, Brazil

    Sidnei Epelman

Authors
  1. Sidnei Epelman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sidnei Epelman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Epelman, S. Preserving Vision in Retinoblastoma Through Early Detection and Intervention. Curr Oncol Rep 14, 213–219 (2012). https://doi.org/10.1007/s11912-012-0226-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11912-012-0226-z

Keywords

Search

Navigation